Hydrocortisone topical: Difference between revisions
(→Common) |
|||
| Line 31: | Line 31: | ||
===Common=== | ===Common=== | ||
*burning | |||
*pruritus | |||
*irritation | |||
*dryness | |||
*folliculitis | |||
*hypertrichosis | |||
*acneiform dermatitis | |||
*hypopigmentation | |||
*perioral dermatitis | |||
*allergic contact dermatitis | |||
*maceration | |||
*secondary infection | |||
*skin atrophy | |||
*striae | |||
*miliaria | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 21:07, 26 June 2015
General
- Type: Topical steroid
- Dosage Forms: 0.5%, 1%, 2.5% crm, lotion, oint
- Common Trade Names:
Adult Dosing
dermatoses, steroid-responsive: apply bid-qid
Pediatric Dosing
dermatoses, steroid-responsive: apply bid-qid
Special Populations
- Pregnancy Rating: C
- Lactation: Probably safe
- Renal Dosing
- Adult: none
- Pediatric: none
- Hepatic Dosing
- Adult: none
- Pediatric: none
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- HPA axis suppresion
- Cushing syndrome
- hyperglycemia
- intracranial HTN (peds pts)
Common
- burning
- pruritus
- irritation
- dryness
- folliculitis
- hypertrichosis
- acneiform dermatitis
- hypopigmentation
- perioral dermatitis
- allergic contact dermatitis
- maceration
- secondary infection
- skin atrophy
- striae
- miliaria
Pharmacology
- Half-life: 8-12h
- Metabolism: liver primarily; CYP450
- Excretion: urine
- Mechanism of Action: exact mechanim of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple gluocorticoid and mineralocorticoid effects